Benactyzine Hydrochloride
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 329310

CAS#: 57-37-4 (HCl)

Description: Benactyzine Hydrochloride, also known as Suavitil, is a centrally acting muscarinic antagonist. Benactyzine has been used in the treatment of depression and is used in research to investigate the role of cholinergic systems on behavior.

Chemical Structure

img
Benactyzine Hydrochloride
CAS# 57-37-4 (HCl)
Instruction

Theoretical Analysis

MedKoo Cat#: 329310
Name: Benactyzine Hydrochloride
CAS#: 57-37-4 (HCl)
Chemical Formula: C20H26ClNO3
Exact Mass: 0.00
Molecular Weight: 363.882
Elemental Analysis: C, 66.02; H, 7.20; Cl, 9.74; N, 3.85; O, 13.19

Price and Availability

Size Price Availability Quantity
5g USD 340 2 weeks
Bulk inquiry

Synonym: Benactyzine Hydrochloride; EA 2092; EA-2092; EA2092; Suavitil; Phebex; Phobex; Cedad; Cevanol; Deprol; Lucidil; Morcain; Nutinal; Parasan

IUPAC/Chemical Name: 2-(diethylamino)ethyl 2-hydroxy-2,2-diphenylacetate hydrochloride

InChi Key: ZCEHOOLYWQBGQO-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H25NO3.ClH/c1-3-21(4-2)15-16-24-19(22)20(23,17-11-7-5-8-12-17)18-13-9-6-10-14-18;/h5-14,23H,3-4,15-16H2,1-2H3;1H

SMILES Code: OC(C1=CC=CC=C1)(C2=CC=CC=C2)C(OCCN(CC)CC)=O.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info: Related CAS# 302-40-9 (Benactyzine) 57-37-4 (Benactyzine Hydrochloride)

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 363.88 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Brown B, Haegerstrom-Portnoy G, Baker R, Adams AJ, Jones RT. Effects of benactyzine hydrochloride on dynamic vision functions. Aviat Space Environ Med. 1982 Nov;53(11):1123-8. PubMed PMID: 7150174.

2: Siedlanowska H, Krówczyński L. [Kinetics of decomposition of benzilic acid esters. 3. Study of kinetics of decomposition of benactyzine hydrochloride and methyliodide and diphemin hydrochloride]. Acta Pol Pharm. 1966;23(6):505-16. Polish. PubMed PMID: 5960081.

3: GLOW PH. The blocking effect of benactyzine hydrochloride on a behaviour disturbance induced with lysergic acid diethylamide. Br J Psychol. 1959 Nov;50:338-48. PubMed PMID: 13828510.

4: BATEMAN JC, CARLTON HM. Meprobamate and benactyzine hydrochloride (deprol) as adjunctive therapy for patients with advanced cancer. Antibiotic Med Clin Ther (New York). 1959 Nov;6:648-52. PubMed PMID: 13797484.

5: LAMPHIER TA. Benactyzine hydrochloride; the treatment of one hundred hospitalized patients. Conn Med. 1959 Apr;23(4):220-3. PubMed PMID: 13639572.

6: SMITH GW, UHR L, POLLARD JC, MILLER JG. An exploratory study of the behavioral effects of suavitil (benactyzine hydrochloride). Med Bull (Ann Arbor). 1958 Oct;24(10):402-7. PubMed PMID: 13603890.

7: ALEXANDER L. Chemotherapy of depression; use of meprobamate combined with benactyzine (2-diethylaminoethyl benzilate) hydrochloride. J Am Med Assoc. 1958 Mar 1;166(9):1019-23. PubMed PMID: 13502099.

8: WELSH AL, EDE M. Experience with benactyzine hydrochloride (suavitil) in dermatologic practice. AMA Arch Derm. 1957 Oct;76(4):466-70. PubMed PMID: 13457433.

9: MACLEAN RE. Benactyzine hydrochloride (suavitil) in out-patient psychiatric treatment: preliminary study. Med J Aust. 1957 Jan 19;44(3):67-70. PubMed PMID: 13399522.

10: Longrée R. [The hydroxylaminolysis kinetics of benactyzine hydrochloride (author's transl)]. J Pharm Belg. 1977 Mar-Apr;32(2):167-78. French. PubMed PMID: 894477.

11: SETTEL E. Treatment of depression in the elderly with a meprobamate-benactyzine hydrochloride combination (deprol). Antibiotic Med Clin Ther (New York). 1960 Jan;7:28-32. PubMed PMID: 14445207.

12: RUCHWARGER A. Use of deprol (meprobamate combined with benactyzine hydrochloride) in the office treatment of depression. Med Ann Dist Columbia. 1959 Aug;28(8):438-41. PubMed PMID: 13673692.

13: ALEXANDER L. Meprobamate combined with 2-diethyl-aminoethyl benzilate hydrochloride (benactyzine). Dis Nerv Syst. 1958 Jul;19(7, Part 2):52-3. PubMed PMID: 13561919.

14: AYD FJ Jr. A clinical report on benactyzine hydrochloride. N Engl J Med. 1957 Oct 3;257(14):669-70. PubMed PMID: 13477367.

15: BERGER FM, HENDLEY CD, LYNES TE. Pharmacology of the psychotherapeutic drug benactyzine (beta-diethylaminoethyl benzilate hydrochloride). Proc Soc Exp Biol Med. 1956 Jul;92(3):563-6. PubMed PMID: 13359467.